Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 63, Issue 1-3, 1997, Pages 9-15

  Huang, Zeqi ^a,b   Fasco, Michael J ^a,b   Kaminsky, Laurence S ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE; ESTRONE SULFATASE; ESTRONE SULFATE; FLAVONOID; KAEMPFEROL; NARINGENIN; QUERCETIN; SULFATASE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER; LIVER MICROSOME; MICROSOME;

AGED; ESTROGEN ANTAGONISTS; FEMALE; FLAVANONES; FLAVONOIDS; HUMANS; KAEMPFEROLS; MALE; MICROSOMES, LIVER; MIDDLE AGED; QUERCETIN; RNA, MESSENGER; SULFATASES;

EID: 0031457707     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00065-4     Document Type: Article

References (33)

1. Hertog M. G. L. and Hollman P. C. H., Potential health effects of the dietary flavonol quercetin. European Journal of Clinical Nutrition 50 (1996) 63-71.
2. Kuhnau J., The flavonoids: a class of semi-essential food components: their role in human nutrition. World Review of Nutrition and Diet 24 (1976) 117-120.
3. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B. and Kromhout D., Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen Elderly Study. Lancet 342 (1993) 1007-1011.
4. Mukkhtar H., Das M., Khan W. A., Wang Z. Y., Bik D. P. and Bickers D. R., Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorgenesis in mice. Cancer Research 48 (1988) 2361-2365.
5. Kato R., Nakadate T., Tamamoto S. and Sugimura T., Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4 (1983) 1301-1305.
6. Verma A. K., Johnson J. A., Gould M. N. and Tanner M. A., Inhibition of 7,12-dimethylbenz(α)anthracene and N-nitro-somethylurea induced rat mammary cancer by dietary flavonol quercetin. Cancer Research 48 (1988) 5754-5758.
7. Santner S. J., Feil P. D. and Santen R. J., In situ estrogen production via estrone sulfatase pathways in breast tumors: relative importance versus the aromatase pathway. Journal of Clinical Endocrinology and Metabolism 59 (1984) 29-33.
8. Pasqualini J. R., Chetrite G., Blacker C., Feinstein M. C., Eelalonde L., Talbi M. and Maloche C., Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activitties in pre-and post-menopausal breast cancer patients. Journal of Clinical Endocrinology and Metabolism 81 (1996) 1460-1464.
9. Reed M. J., Lai L. C., Owen A. M., Singh A., Coldham N. G., Purohit A., Ghilchik M. W., Shaikh N. A. and James V. H. T., Effect of treatment with 4-hydroxy-androstenedione in the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer. Cancer Research 50 (1990) 193-196.
10. Jasonni V. M., Naldi S., La Marca L., Bulletti C., Ciotti P., Vignudelli A. and Flamigni C., Preliminary report on post-menopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. Cancer Detection and Prevention 9 (1986) 331-335.
11. Nguyen B. L., Ferme I., Chetirte G. and Pasqualini J. R., Action of danazol of the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells. Journal of Steroid Biochemistry and Molecular Biology 46 (1993) 17-23.
12. James V. H. T., Reed M. J. and Purohit A., Inhibition of estrogen synthesis in postmenopausal women with breast cancer. Journal of Steroid Biochemistry and Molecular Biology 43 (1992) 149-153.
13. Yamamoto T., Yokota K., Urabe M., Kitawaki J. and Honjo H., The inhibitory effect of medroxyprogesterone acetate on steroid sulfatase in human uterine endometrial cancer cells. Endocrine-Related Cancer 3 (1996) 337-340.
14. Dibbelt L., Li P.-K., Pillai R. and Knuppen R., Inhibition of human placental sterylsulfatase by synthetic analogs of estrone sulfate. Journal of Steroid Biochemistry and Molecular Biology 50 (1994) 261-266.
15. Evans T. R. J., Rowlands M. G., Jarman M. and Coombes R. C., Inhibition of estrone sulfatase enzymes in human placenta and human breast carcinoma. Journal of Steroid Biochemistry and Molecular Biology 39 (1991) 493-499.
16. Purohit A., Williams G. J., Howarth N. M., Potter B. V. L. and Reed M. J., Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Biochemistry 34 (1995) 11508-11514.
17. Purohit A., Williams G. J., Roberts C. J., Potter B. V. L. and Reed M. J., in vivo inhibition of estrone sulfatase and dehydroepiandrosterone sulfatase by estrone-3-O-sulphamate. International Journal of Cancer 63 (1995) 106-111.
18. Howarth N. M., Purohit A., Reed M. J. and Potter B. V. L., Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. Journal of Medicinal Chemistry 37 (1994) 219-221.
19. Zhang Z. Y., Fasco M. J., Huang Z., Guengerich P. F. and Kaminsky L. S., Human P4501A1 and P4501A2: R-warfarin metabolism as a probe. Drug Metabolism and Disposition 23 (1995) 1339-1345.
20. Huang Z., Fasco M. J. and Kaminsky L. S., Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. BioTechniques 20 (1996) 1012-1020.
21. Huang Z., Fasco M. J., Figge H. L., Keyomarsi K. and Kaminsky L. S., Expression of cytochrome P450s in human breast tissues and tumors. Drug Metabolism and Disposition 24 (1996) 899-905.
22. Fasco M. J., Treanor C. P., Spivack S., Figge H. L. and Kaminsky L. S., Quantitative RNA-polymerase chain reaction-DNA analysis by capillary electrophoresis and laser-induced fluorescence. Analytical Biochemistry 224 (1995) 140-147.
23. Kellis J. T. Jr and Vickery L. E., Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225 (1984) 1032-1034.
24. Wang C., Makela T., Hase T., Adlercreutz H. and Lurzer M. S., Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. Journal of Steroid Biochemistry and Molecular Biology 50 (1994) 205-212.
25. Haning R. V. Jr, Hackett R. J. and Canick J. A., Steroid sulfatase in the human ovary and placenta: enzyme kinetics and phosphate inhibition. Journal of Steroid Biochemistry and Molecular Biology 41 (1992) 161-165.
26. Prost O. and Adessi G. L., Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies. Journal of Clinical Endocrinology and Metabolism 56 (1983) 653-661.
27. Pasqualini J. R., Maloche C., Maroni M. and Chetrite G., Effect of the progestagen Promegestone (R-5020) on mRNA of the estrone sulfatase in the MCF-7 human mammary cancer cells. Anticancer Research 14 (1994) 1589-1593.
28. Farooqui A. A., Clinical and metabolic aspects of sulfohydrolases in man. Advances in Clincial Chemistry 26 (1987) 157-201.
29. Cuevas-Covarrubias S. A., Juarez-Oropeza M. A., Miranda-Zamora R. and Diaz-Zagoya J. C., Comparative analysis of human steroid sulfatase activity in prepubertal and postpubertal males and females. Biochemistry and Molecular Biology 30 (1993) 691-695.
30. Munroe D. G. and Chang P. L., Tissue-specific expression of human arylsulfatase-C isozymes and steroid sulfatase. American Journal of Human Genetics 40 (1987) 102-114.
31. Palmer, T. (1991) Understanding Enzymes, 3rd Edn. Ellis Horwood, London, pp. 139-156.
32. Ruoff B. M. and Daniel W. L., Comparative biochemistry of mammalian arylsulfatase C and steroid sulfatase. Comparative Biochemistry and Physiology 98B (1991) 313-322.
33. Franco B., Meroni G., Parenti G., Levilliers J., Bernard L., Gebbia M., Cox L., Maroteaux P., Sheffield L., Rappold G. A., Andria G., Petit C. and Ballabio A., A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 81 (1995) 15-25.